STAT3 mediates bone marrow mesenchymal stem cell VEGF production

Journal of Molecular and Cellular Cardiology

Volumn 42, Issue 6, 2007, Pages 1009-1015

  Wang, Meijing ^a   Zhang, Wenjun ^a   Crisostomo, Paul ^a   Markel, Troy ^a   Meldrum, Kirstan K ^a   Fu, Xin Y ^a   Meldrum, Daniel R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Growth substances; Hypoxia; Mesenchymal stromal cell; Signal transduction; STAT3

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; STAT3 PROTEIN; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME INHIBITION; HYPOXIA; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; MESENCHYMAL STEM CELLS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; STAT3 TRANSCRIPTION FACTOR; STROMAL CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 34249722245     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.04.010     Document Type: Article

References (34)

1. Silva G.V., Litovsky S., Assad J.A., Sousa A.L., Martin B.J., Vela D., et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111 (2005) 150-156
2. Kawada H., Fujita J., Kinjo K., Matsuzaki Y., Tsuma M., Miyatake H., et al. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 104 (2004) 3581-3587
3. Nagaya N., Kangawa K., Itoh T., Iwase T., Murakami S., Miyahara Y., et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112 (2005) 1128-1135
4. Laflamme M.A., Myerson D., Saffitz J.E., and Murry C.E. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ. Res. 90 (2002) 634-640
5. Jackson K.A., Majka S.M., Wang H., Pocius J., Hartley C.J., Majesky M.W., et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107 (2001) 1395-1402
6. Wang M., Tsai B.M., Crisostomo P.R., and Meldrum D.R. Pretreatment with adult progenitor cells improves recovery and decreases native myocardial proinflammatory signaling after ischemia. Shock 25 (2006) 454-459
7. Wang M., Crisostomo P.R., Herring C., Meldrum K.K., and Meldrum D.R. Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291 (2006) R880-R884
8. Uemura R., Xu M., Ahmad N., and Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ. Res. 98 (2006) 1414-1421
9. Tang Y.L., Zhao Q., Zhang Y.C., Cheng L., Liu M., Shi J., et al. Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul. Pept. 117 (2004) 3
10. Jung J.E., Lee H.G., Cho I.H., Chung D.H., Yoon S.H., Yang Y.M., et al. STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. FASEB J. 19 (2005) 1296-1298
11. Xu Q., Briggs J., Park S., Niu G., Kortylewski M., Zhang S., et al. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene 24 (2005) 5552-5560
12. Duyndam M.C., Hulscher S.T., van der Wall E., Pinedo H.M., and Boven E. Evidence for a role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arsenite. J. Biol. Chem. 278 (2003) 6885-6895
13. Fu X.Y. STAT3 in immune responses and inflammatory bowel diseases. Cell Res. 16 (2006) 214-219
14. Welte T., Zhang S.S., Wang T., Zhang Z., Hesslein D.G., Yin Z., et al. STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1879-1884
15. Peister A., Mellad J.A., Larson B.L., Hall B.M., Gibson L.F., and Prockop D.J. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103 (2004) 1662-1668
16. Wagers A.J., and Weissman I.L. Plasticity of adult stem cells. Cell 116 (2004) 639-648
17. Jiang S., Haider H., Idris N.M., Salim A., and Ashraf M. Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair. Circ. Res. 99 (2006) 776-784
18. Carmeliet P., Lampugnani M.G., Moons L., Breviario F., Compernolle V., Bono F., et al. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98 (1999) 147-157
19. Wang Y., Haider H.K., Ahmad N., Xu M., Ge R., and Ashraf M. Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair. J. Mol. Cell. Cardiol. 40 (2006) 736-745
20. Carmeliet P., Ng Y.S., Nuyens D., Theilmeier G., Brusselmans K., Cornelissen I., et al. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat. Med. 5 (1999) 495-502
21. Rehman J., Traktuev D., Li J., Merfeld-Clauss S., Temm-Grove C.J., Bovenkerk J.E., et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109 (2004) 1292-1298
22. Grunewald M., Avraham I., Dor Y., Bachar-Lustig E., Itin A., Yung S., et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124 (2006) 175-189
23. Malaguarnera L., Imbesi R., Di Rosa M., Scuto A., Castrogiovanni P., Messina A., et al. Action of prolactin, IFN-gamma, TNF-alpha and LPS on heme oxygenase-1 expression and VEGF release in human monocytes/macrophages. Int. Immunopharmacol. 5 (2005) 1458-1469
24. Thobe B.M., Frink M., Choudhry M.A., Schwacha M.G., Bland K.I., and Chaudry I.H. Src family kinases regulate p38 MAPK-mediated IL-6 production in Kupffer cells following hypoxia. Am. J. Physiol. 291 (2006) C476-C482
25. Jarrar D., Wang P., Song G.Y., Cioffi W.G., Bland K.I., and Chaudry I.H. Inhibition of tyrosine kinase signaling after trauma-hemorrhage: a novel approach for improving organ function and decreasing susceptibility to subsequent sepsis. Ann. Surg. 231 (2000) 399-407
26. Schwacha M.G., Chaudry I.H., and Alexander M. Regulation of macrophage IL-10 production postinjury via beta2 integrin signaling and the P38 MAP kinase pathway. Shock 20 (2003) 529-535
27. Song G.Y., Chung C.S., Chaudry I.H., and Ayala A. MAPK p38 antagonism as a novel method of inhibiting lymphoid immune suppression in polymicrobial sepsis. Am. J. Physiol. Cell Physiol. 281 (2001) C662-C669
28. Sauer H., Bekhite M.M., Hescheler J., and Wartenberg M. Redox control of angiogenic factors and CD31-positive vessel-like structures in mouse embryonic stem cells after direct current electrical field stimulation. Exp. Cell Res. 304 (2005) 380-390
29. Wang F.S., Wang C.J., Chen Y.J., Chang P.R., Huang Y.T., Sun Y.C., et al. Ras induction of superoxide activates ERK-dependent angiogenic transcription factor HIF-1alpha and VEGF-A expression in shock wave-stimulated osteoblasts. J. Biol. Chem. 279 (2004) 10331-10337
30. Niu G., Wright K.L., Huang M., Song L., Haura E., Turkson J., et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21 (2002) 2000-2008
31. Funamoto M., Fujio Y., Kunisada K., Negoro S., Tone E., Osugi T., et al. Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes. J. Biol. Chem. 275 (2000) 10561-10566
32. Osugi T., Oshima Y., Fujio Y., Funamoto M., Yamashita A., Negoro S., et al. Cardiac-specific activation of signal transducer and activator of transcription 3 promotes vascular formation in the heart. J. Biol. Chem. 277 (2002) 6676-6681
33. Takeda K., Noguchi K., Shi W., Tanaka T., Matsumoto M., Yoshida N., et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 3801-3804
34. Theiss A.L., Simmons J.G., Jobin C., and Lund P.K. Tumor necrosis factor (TNF) alpha increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2. J. Biol. Chem. 280 (2005) 36099-36109